Rmf. Vanderweiden et al., WHICH PROSTANOID METABOLITES SHOULD BE DETERMINED FOR THE STUDY OF REPRODUCTIVE PROCESSES, Prostaglandins, leukotrienes and essential fatty acids, 58(3), 1998, pp. 205-207
The non-enzymatic metabolites of prostacyclin (PGI(2)) and thromboxane
A(2) (TXA(2)), 6-keto-prostaglandin F-1 alpha (6-keto-PGF(1 alpha)) a
nd thromboxane B-2 (TXB2), and their 2,3-dinor metabolites, 2,3-dinor-
6-keto-PGF(1 alpha) and 2,3-dinor TXB2, were measured in early morning
urine samples in 24 in vitro fertilization (IVF) cycles in 24 women a
nd in 27 women who became pregnant after IVF and embryo transfer (ET).
The sum of the non-enzymatic metabolites and their 2,3-dinor metaboli
tes was considered to be a reflection of total PGI(2) and total TXA(2)
production in vivo. Both the ratio of 'total' PGI(2)/'total' TXA(2) a
nd the ratio of the 2,3-dinor metabolites were calculated. TXB2 concen
trations showed virtually no change and the ratios of the non-enzymati
c metabolites of PGI(2) and TXA(2) versus their 2,3-dinor metabolites
remained relatively constant. As a consequence, the ratio of 2,3-dinor
-6-keto-PGF(1 alpha)/2,3-dinor-TXB2 was a close reflection of the rati
o of 'total' PGI(2)/'total' TXA(2), although the latter ratio was sign
ificantly higher all the time. We conclude that for comparative studie
s on the balance between PGI(2) and TXA(2) in IVF cycles and during ge
station, the determination of the 2,3-dinor metabolites alone can repl
ace the measurement of all four metabolites.